SCHEMBL24668201

SCHEMBL24668201

CSOC(=O)C1=CCCCC1S(=O)(=O)Nc1ccc(CNC(C)=O)cc1F

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TLR4 O00206 5/20 0.56
TRPV1 Q8NER1 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24668068 0.88 TLR4 (0.56) TLR4TRPV1
SCHEMBL26422784 0.81 TLR4 (0.57) TLR4
SCHEMBL26428668 0.81 TLR4 (0.73) TLR4TRPV1
SCHEMBL23417855 0.80 TLR4 (0.50) TLR4
SCHEMBL26418211 0.80 TLR4 (0.56) TLR4TRPV1
SCHEMBL23417719 0.78 TLR4 (0.62) TLR4TRPV1
SCHEMBL23417930 0.78 TLR4 (0.62) TLR4
SCHEMBL23417931 0.76 TLR4 (0.45) TLR4
SCHEMBL24668088 0.75 TLR4 (0.59) TLR4TRPV1
SCHEMBL871825 0.75 TLR4 (0.66) TLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022246086-A1 ANTIBODY DRUG CONJUGATES USING MATES TECHNOLOGY FOR DELIVERING CYTOTOXIC AGENTS BIOHAVEN THERAPEUTICS LTD. (US) 2022-11-24 WO disclosed